Portfolio
Aderis Pharmaceuticals, Inc. was a biopharmaceutical company specializing in the treatment of cardiovascular, renal and neurological diseases.
The company’s expertise was in the discovery and development of small-molecule drug candidates that act selectively on enzymes or subtypes of receptors that regulate important physiological processes.
In 2005 Aderis Pharmaceuticals, Inc. was acquired by Schwarz Pharma, Inc., a German pharmaceutical company.
Status: Realised
Contact person: Erik Amble